Print

MRC V001

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Human Immunodeficiency Virus Envelope Preparation (rgp120) With Novel Potent Adjuvants

Trial Details:

I Completed
Medical Research Council (MRC) November 13, 1995
rgp120w61d Env B
rgp120w61d Protein
United Kingdom 30
http://www.ctu.mrc.uk/ctunet/